At the 37th Annual News and Documentary Emmy® Awards, PBS was awarded an Outstanding Science and Technology Programming Emmy for "TWICE BORN: Stories from The Special Delivery Unit," featuring Children's Hospital of Philadelphia.

A CHOP scientist found that RNA molecules help control how the immune system affects infection and inflammation. The research may yield new treatments for asthma, IBD and other diseases. 

Early introduction of higher level “instrumental skills” allows for time and practice to help individuals with Down syndrome achieve independence in their daily life.

Find practical advice to help individuals with Down syndrome take charge of their healthcare, find employment, and plan for the transition to life after high school.

Members of the CHOP Cancer Center team work to ensure that our patients’ and families’ transition to outpatient care is smooth and successful.

The Psychosocial Services Program in the Division of Oncology at Children’s Hospital of Philadelphia provides comprehensive psychosocial services for children with cancer and members of their families.

CHOP recently launched a Bone and Soft Tissue Tumor Program, a collaboration between teams from Orthopedics and Oncology.

CHOP's revolutionary T-cell immunotherapy was featured at “Cellular Horizons: The Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact,” an exclusive international event at the Vatican.

The Division of Genomic Diagnostics at Children’s Hospital of Philadelphia has launched AUDIOME, a comprehensive genetic test for the diagnosis of nonsyndromic hearing loss in children (NSHL).

Dr. Hakon Hakonarson will address a major conference in precision medicine at which experts review progress in applying DNA discovery to advancing human health.